Generics

Filter

Current filters:

None

Popular Filters

29 to 53 of 1161 results

Supernus notified of Par Pharma ANDA filing for Trokendi XR generic

09-12-2014

US drugmaker Supernus Pharmaceuticals says that it has received a Paragraph IV Notice Letter from privately-held…

GenericsNeurologicalPar PharmaceuticalsPatentsRegulationSupernus PharmaceuticalsTrokendi XRUSA

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

AstraZeneca wins in US Nexium pay-for-delay litigation

AstraZeneca wins in US Nexium pay-for-delay litigation

07-12-2014

Anglo-Swedish pharma major AstraZeneca revealed on Friday that a jury in the US District Court for the…

AstraZenecaGastro-intestinalsGenericsLegalNexiumPatentsRanbaxyUSA

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

FDA grants tentative approval to Mylan's two dosages of abacavir/lamivudine tablets for pediatric HIV

05-12-2014

The US Food and Drug Administration has granted tentative approval for New Drug Applications by US generic…

Abacavir Sulfate and Lamivudine TabletsAnti-viralsGenericsMylanRegulationUSA

FDA guidance for prospective ANDA sponsors

FDA guidance for prospective ANDA sponsors

04-12-2014

The US Food and Drug Administration has issued new guidance in its efforts to assist in certain circumstances…

FDAGenericsPharmaceutical sciencesRegulationUSA

Nippon Kayaku launches biosimilar Remicade in Japan

Nippon Kayaku launches biosimilar Remicade in Japan

01-12-2014

Japanese drugmaker Nippon Kayaku has launched the sale of Infliximab BS for IV Infusion 100mg, a biosimilar…

Anti-Arthritics/RheumaticsBiosimilarsGenericsinfliximabJapanJohnson & JohnsonMarkets & MarketingNippon KayakuRemicade

Global oncology biosimilars market 2014-2018

28-11-2014

The global oncology biosimilars market is expected to expand at a compound annual growth rate (CAGR)…

BioconBiosimilarsCellTrionDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingMylanSandoz

Russia tightens procedure for accelerated registration of drugs

27-11-2014

Only the first three generics, along with generics intended for minors, as well as orphan drugs, will…

GenericsRegulationRussia

AbbVie acquires API facility in Singapore; Amgen completes new unit

AbbVie acquires API facility in Singapore; Amgen completes new unit

26-11-2014

US pharma major AbbVie has acquired a small-molecule active pharmaceutical ingredient (API) manufacturing…

AbbVieAmgenBiotechnologyGenericsProductionSingapore

Mylan confirms first-to-file patent challenge relating to Brevibloc

25-11-2014

US generic drugmaker Mylan today confirmed that it and several subsidiaries have been sued by US drugmaker…

Baxter InternationalBreviblocCardio-vascularGenericsLegalMylanPatentsRegulationUSA

Supernus sues Zydus for infringement of Trokendi XR patents

25-11-2014

US drugmaker Supernus Pharmaceuticals has sued generic drug makers Zydus Pharmaceuticals (USA) and Indian…

GenericsLegalNeurologicalPatentsSupernus PharmaceuticalsUSAZydus Cadila

GPhA slams mischaracterized facts about generic drug pricing

GPhA slams mischaracterized facts about generic drug pricing

24-11-2014

Commenting on recent evaluations of generic drug prices, Ralph Neas, president and chief executive of…

GenericsLegalPoliticsPricingUSA

China pharma excipients market to reach $8.9 billion in 2017

China pharma excipients market to reach $8.9 billion in 2017

24-11-2014

Currently, pharmaceutical excipients account for about 2%-3% of China's total output value of pharmaceutical…

ChinaGenericsMarkets & MarketingProduction

Beximco Pharma receives GMP approval from Health Canada

Beximco Pharma receives GMP approval from Health Canada

24-11-2014

Bangladeshi drugmaker Beximco Pharma has received Good Manufacturing Practices approval from Health Canada,…

BangladeshBeximco PharmaceuticalsCanadaGenericsProductionRegulation

Cipla links with SII for affordable pediatric vaccines in Europe

20-11-2014

The European subsidiary of Indian drugmaker Cipla has entered a distribution agreement with Serum Institute…

CiplaEuropeGenericsMarkets & MarketingSerum Institute of IndiaVaccines

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

17-11-2014

The Competition Commission has asked Indian generics company Sun Pharmaceutical Industries, which acquired…

GenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceutical

Good results from Stada Arz, despite challenging conditions

13-11-2014

German drugmaker Stada Arzneimittel has posted financial results for the first nine months of 2014, showing…

Eastern EuropeFinancialGenericsRussiaSTADA Arzneimittel

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

29 to 53 of 1161 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top